Table 2.
Changes in ocular and systemic parameters at 3 months after the instillation of topical prostaglandin analogs (N = 28).
| Before treatment | After treatment | p value∗ | |
|---|---|---|---|
| IOP (mmHg) | 15.95 ± 2.81 | 11.82 ± 2.31 | 0.001 |
| MOPP (mmHg) | 42.95 ± 12.48 | 46.25 ± 7.18 | 0.004 |
| MBP (mmHg) | 85.58 ± 13.15 | 87.70 ± 11.73 | 0.175 |
| Heart rate (beats/min) | 70.92 ± 12.57 | 69.90 ± 10.41 | 0.657 |
| MBRT (AU) | 10.43 ± 1.65 | 10.10 ± 1.80 (97.2 ± 11.0) | 0.136 (0.143) |
| Fluctuation (AU) | 13.05 ± 3.44 | 12.23 ± 3.34 (94.8 ± 15.7) | 0.106 (0.122) |
| BOS (AU) | 77.39 ± 5.79 | 78.65 ± 5.89 (101.7 ± 4.8) | 0.122 (0.116) |
| ATI (AU) | 31.56 ± 3.58 | 30.44 ± 3.82 (96.7 ± 7.8) | 0.034 (0.031) |
| BOT (AU) | 51.81 ± 4.72 | 51.89 ± 4.75 (99.8 ± 6.2) | 0.909 (0.982) |
| Skew (AU) | 11.13 ± 1.94 | 11.34 ± 1.90 (102.9 ± 13.4) | 0.301 (0.290) |
| Number of glaucoma medications | 0 | 1 | <0.001 |
The data are presented as means ± standard deviations. ∗Differences in values before and after treatment were determined using analysis of variance with the Wilcoxon test. The ratios calculated based on the pretreatment values and p values based on the ratios were presented in the square brackets. IOP: intraocular pressure; MOPP: mean ocular perfusion pressure; MBP: mean blood pressure; MBRT: mean blur rate in the tissue area of the optic disc; AU: arbitrary unit; BOS: blowout score; ATI: acceleration time index; BOT: blowout time.